Global Ovarian Cancer Market 2014-2018

グローバルにおける卵巣がん治療市場(2014-2018)

◆タイトル:Global Ovarian Cancer Market 2014-2018
◆商品コード:IRTNTR3651
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2014年6月
◆ページ数:45
◆資料形式:pdf / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD2,000 ⇒換算¥220,000見積依頼/購入/質問フォーム
Five UserUSD2,300 ⇒換算¥253,000見積依頼/購入/質問フォーム
Enterprise License(社内共有可)USD3,000 ⇒換算¥330,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

本調査レポートでは、"グローバルにおける卵巣がん治療市場(2014-2018)"について調査・分析し、エグゼクティブサマリー、市場概観、市場規模及び予測、種類別分析、主要地域別分析、市場シェア、購買基準、市場成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析等の情報をお届けいたします。

About Ovarian Cancer and its therapy
Ovarian cancer is a condition where a malignancy forms in the ovarian tissue and is caused by uncontrollable cell growth. It is one of the major gynaecological cancers worldwide and a leading cause of death. Ovarian cancer is difficult to diagnose in the initial stages because the symptoms are similar to that of gastric disorders like bloating, abdominal discomfort, difficulty in eating in the early stage and nausea, vomiting, constipation and diarrhoea in the later stages. It is often diagnosed in advanced stages when the metastasis has set in because the diagnostic techniques are not well-developed. Ovarian cancer can be treated by using chemotherapy, targeted therapy, and surgery. Although the market has a limited number of drugs for the treatment of ovarian cancer currently, a strong product pipeline is in development for the forecast period.
TechNavio’s analysts forecast the Global Ovarian Cancer market will grow at a CAGR of 13.85 percent over the period 2013-2018.
Covered in this Report
This report covers the present scenario and the growth prospects of the Global Ovarian Cancer market for the period 2013–2018. To calculate the market size, the report considers the revenue generated from the sales of various drugs used in the treatment of ovarian cancer that are available in the market.
TechNavio’s report, the Global Ovarian Cancer Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Ovarian Cancer market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
• Americas
• EMEA
• APAC
Key Vendors
• Bristol Myers Squibb Company
• Eli Lilly and Company
• GlaxoSmithKline plc
• Janssen Pharmaceuticals Inc.
• F. Hoffman-La Roche Ltd
Other Prominent Vendors

• Aprea AB
• Aetera Zenteris Inc.
• Amgen Inc.
• Astra Zeneca plc
• Bionumerik Pharmaceuticals Inc.
• Boehringer Ingelheim GmbH
• Genentech Inc.
• MEI Pharmaceuticals Inc.
• Nektar Therapeutics
• NeoPharm Inc.
• Novogen Inc.
• Oasmia Pharmaceuticals AB
• Synta Pharmaceuticals Corp.
Key Market Driver
• Promising Drug Pipeline.
• For a full, detailed list, view our report.
Key Market Challenge
• Lack of Accurate Diagnosis of Ovarian Cancer.
• For a full, detailed list, view our report.
Key Market Trend
• Increase in the Funding Activities.
• For a full, detailed list, view our report.
Key Questions Answered in this Report
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【資料の目次】

01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
Product Profiles
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Rate of Incidence and Prevalence
08. Market Segmentation by Type of Therapy
08.1.1 Chemotherapy
08.1.2 Targeted Therapy
09. Pipeline Portfolio
10. Geographical Segmentation
11. Buying Criteria
12. Market Growth Drivers
13. Drivers and their Impact
14. Market Challenges
15. Impact of Drivers and Challenges
16. Market Trends
17. Trends and their Impact
18. Vendor Landscape
18.1 Competitive Scenario
18.1.1 Key News
18.1.2 Mergers and Acquisitions
18.2 Market Share Analysis 2013
18.3 Other Prominent Vendors
19. Key Vendor Analysis
20. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Ovarian Cancer Market 2013-2018 (US$ billion)
Exhibit 3: Global Ovarian Cancer Market 2013-2018 by Type of Therapy
Exhibit 4: Snapshot of Ovarian Cancer Pipeline 2013
Exhibit 5: Global Ovarian Cancer Market by Geographical Segmentation 2013



【掲載企業】

Bristol Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline plc, Janssen Pharmaceuticals Inc., F. Hoffman-La Roche Ltd, Aprea AB, Aetera Zenteris Inc., Amgen Inc., Astra Zeneca plc, Bionumerik Pharmaceuticals Inc., Boehringer Ingelheim GmbH, Genentech Inc., MEI Pharmaceuticals Inc., Nektar Therapeutics, NeoPharm Inc., Novogen Inc., Oasmia Pharmaceuticals AB, Synta Pharmaceuticals Corp.

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[グローバルにおける卵巣がん治療市場(2014-2018)] (Global Ovarian Cancer Market 2014-2018 / IRTNTR3651)販売に関する免責事項
[グローバルにおける卵巣がん治療市場(2014-2018)] (Global Ovarian Cancer Market 2014-2018 / IRTNTR3651)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆